TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients
Clinical trial NCT00071097 · COMPLETED
Trial details
- NCT number
- NCT00071097
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2005-02-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.